| Literature DB >> 33034553 |
Kelle C Freel1,2, Stephanie Fouteau3, David Roche3, Julien Farasin2, Aline Huber2, Sandrine Koechler4,2, Martina Peres2, Olfa Chiboub2, Hugo Varet5,6, Caroline Proux6, Julien Deschamps7, Romain Briandet7, Rachel Torchet3, Stephane Cruveiller3, Didier Lièvremont2, Jean-Yves Coppée6, Valérie Barbe3, Florence Arsène-Ploetze2,4.
Abstract
Thiomonas bacteria are ubiquitous at acid mine drainage sites and play key roles in the remediation of water at these locations by oxidizing arsenite to arsenate, favouring the sorption of arsenic by iron oxides and their coprecipitation. Understanding the adaptive capacities of these bacteria is crucial to revealing how they persist and remain active in such extreme conditions. Interestingly, it was previously observed that after exposure to arsenite, when grown in a biofilm, some strains of Thiomonas bacteria develop variants that are more resistant to arsenic. Here, we identified the mechanisms involved in the emergence of such variants in biofilms. We found that the percentage of variants generated increased in the presence of high concentrations of arsenite (5.33 mM), especially in the detached cells after growth under biofilm-forming conditions. Analysis of gene expression in the parent strain CB2 revealed that genes involved in DNA repair were upregulated in the conditions where variants were observed. Finally, we assessed the phenotypes and genomes of the subsequent variants generated to evaluate the number of mutations compared to the parent strain. We determined that multiple point mutations accumulated after exposure to arsenite when cells were grown under biofilm conditions. Some of these mutations were found in what is referred to as ICE19, a genomic island (GI) carrying arsenic-resistance genes, also harbouring characteristics of an integrative and conjugative element (ICE). The mutations likely favoured the excision and duplication of this GI. This research aids in understanding how Thiomonas bacteria adapt to highly toxic environments, and, more generally, provides a window to bacterial genome evolution in extreme environments.Entities:
Keywords: acid mine drainage (AMD); adaptation; arsenic; comparative genomics; genome evolution; genomic islands
Year: 2020 PMID: 33034553 PMCID: PMC7660254 DOI: 10.1099/mgen.0.000447
Source DB: PubMed Journal: Microb Genom ISSN: 2057-5858
Fig. 1.Depictions of cultivation methods to obtain variants capable of survival at higher arsenite concentrations than the parent strain sp. CB2. (a) Determination of the number of variants generated after growth in planktonic or biofilm culture conditions. A planktonic culture was inoculated from a pre-culture, then used to start an initial culture to inoculate planktonic and biofilm cultures grown in (1) 0, (2) 2.67 or (3) 5.33 mM arsenite [As(III)]. Three replicates were used for biofilms (wells) and planktonic culture (flasks) per concentration. The percentage of variants was measured in the upper phase (detached cells) and the lower phase (attached cells) of the biofilm. Dilutions were made prior to spreading on solid M126 medium with 0 or 10.6 mM arsenite. (b) Generation of ‘super variants’ capable of growth at much higher levels than the parent strain. The biofilm was inoculated from a planktonic culture initially inoculated from a pre-culture. Biofilms were grown for 72 h with one change of medium at 24 h, grown with no arsenic or arsenite concentrations of 1.33, 2.67, 4 or 5.33 mM with two wells per concentration. The detached planktonic cells and the cells attached to the plate were separated prior to variant selection on solid medium containing 13.25, 15.9, 21.2 or 26.5 mM arsenite. This figure was created with bioRENDER (https://biorender.com).
MICs (denoted with an asterisk) and arsenite oxidation activity (denoted with #) of variants selected for their resistance to arsenic and select antibiotics
|
Strain/ variant ID |
Arsenite (mM)* |
Neomycin (mg l−1)* |
Spectinomycin (mg l−1)* |
Gentamicin (mg l−1)* |
Streptomycin (mg l−1)* |
Kanamycin (mg l−1)* |
Arsenite oxidation activity # |
|---|---|---|---|---|---|---|---|
|
CB2 |
12 |
16 |
8 |
4 |
8 |
2 |
++ |
|
Bio17A3 |
23.9 |
|
|
|
|
|
|
|
Bio17B3 |
23.9 |
16 |
8 |
4 |
8 |
2 |
– |
|
Bio16B1 |
15.9 |
|
|
|
|
|
|
|
Sup16A1 |
23.9 |
|
|
|
|
|
|
|
Sup16B3 |
23.9 |
<16 |
8 |
4 |
8 |
2 |
– |
|
Bio14B1 |
18.6 |
<16 |
8 |
4 |
8 |
2 |
|
|
Sup14A1 |
21.3 |
|
|
|
|
|
|
|
Sup14A3 |
21.3 |
|
|
|
|
|
|
|
OC7 |
15.9 |
256 |
512 |
64 |
128 |
128 |
++ |
nt, Not tested.
Fig. 2.Proportion (%) of bacterial cells that appear to be ‘super resistant’ to arsenite (a–c) or resistant to kanamycin (d–f) in strain sp. CB2 (variants). The percentage that represented variants was calculated by dividing the number of resistant cells by the total number of cells, with the boxplot showing median, quartiles and extremes; extreme values are indicated with bars. Crosses highlight the median values. The graphs are from samples grown as described in Fig. 1a for 24 h (a, d), 48 h (b, e) and 72 h (c, f). The red star indicates that the total number of cells was not evaluated for this condition. The data were calculated from three replicates except for samples indicated with the black star; in these cases, data were calculated from two replicates.
Fig. 3.Data analysis of previous RNA-seq experiments [29] revealing changes in expression of various genes in sp. CB2 grown in the presence of arsenite [5.33 mM] or absence of arsenite at 24, 48 and 72 h. Gene expression of 12 selected genes is shown. Each condition was replicated three times. The heatmap is based on the variance-stabilized transformed count matrix that has been adjusted for the replicate effect using the ‘removeBatchEffect’ function or the limma R package (version 3.44.3). Rows and columns have been re-ordered with hierarchical clustering (using the correlation and Euclidean distances, respectively, and the Ward aggregation criterion). The colour scale ranges from −2.5 to +2.5 as the rows of the matrix have been centred.
Size (in nucleotides) of the chromosome and the chromosomal ICE19, as well as plasmids of CB2 and the variants
|
Chromosome |
ICE19 |
pA- |
pB- |
pC- | |
|---|---|---|---|---|---|
|
CB2 |
3 866 172 |
184 821 |
39 434 |
8340 |
0 |
|
OC7 |
3 891 617 |
184 820 |
31 833 |
9355 |
0 |
|
Bio17B3 |
3 874 064 |
184 821 |
0 |
8714 |
204 717 |
|
Sup16B3 |
3 867 933 |
184 921 |
0 |
8082 |
184 759 |
Fig. 4.ICE19 was found in triplicate in the Bio17B3 and the Sup16B3 variants, and 10 mutations were found in the variants in the att regions flanking this ICE19. (a) Read mapping profile obtained from sequencing data. This figure shows profiles for each set of sequencing data (PE, paired-end; MP, mate-pair data) and the three variant genomes, as well as the coverage of the reads mapped at each nucleotide of the CB2 genome. This figure was generated using igv software. (b) Comparison of the attL and attR region of ICE19 in CB2 (at the top) and the att region in Bio17 and Sup16 (at the bottom).